Biodegradable intranasal nanoparticulate drug delivery system of risedronate sodium for osteoporosis

References

• Akesson KK. (2003). New approaches to pharmacological treatment of osteoporosis. Bull World Health Organ 81:657–64
   PubMed Web of Science ®Google Scholar
• Amann LC, Gandal MJ, Lin R, et al. (2010). In vitro–in vivo correlations of scalable PLGA-risperidone implants for the treatment of schizophrenia. Pharm Res 27:1730–37
   PubMed Web of Science ®Google Scholar
• Banji D, Banji OJ, Chiluka VL, Abbagoni S. (2014). Role of Triticum aestivum aqueous extract in glucocorticoid induced osteoporosis in rats. Indian J Exp Biol 52:153–58
   PubMed Web of Science ®Google Scholar
• Blanco MD, Alonso MJ. (1997). Development and characterization of protein loaded poly (lactide-co-glycolide) nanospheres. Eur J Pharm Biopharm 43:287–94
   Web of Science ®Google Scholar
• Budhian A, Siegel SJ, Winey KI. (2007). Haloperidol-loaded PLGA nanoparticles: systematic study of particle size and drug content. Int J Pharm 336:367–75
   PubMed Web of Science ®Google Scholar
• Calvo P, Remunan-Lopez C, Vila-Jata JL, Alonso, MJ. (1997). Chitosan and chitosan: ethylene oxide-propylene oxide block copolymer NPs as novel carriers for proteins and vaccines. Pharm Res 14: 1431–36
   PubMed Web of Science ®Google Scholar
• Corrigan OI, Li X. (2009). Quantifying drug release from PLGA nanoparticulates. Euro J Pharm Sci 37:477–85
   PubMed Web of Science ®Google Scholar
• Deepa S, Fazil M, Ali MM, et al. (2014). Formulation, development and optimization of raloxifene-loaded chitosan nanoparticles for treatment of osteoporosis. Drug Deliv 1-14. [Epub ahead of print]
   Web of Science ®Google Scholar
• Dhanwal DK, Dennison EM, Harvey NC, Cooper C. (2011). Epidemiology of hip fracture: worldwide geographic variation. Ind J Orthop 45:15–22
   PubMed Web of Science ®Google Scholar
• Dunne M, Corrigan O, Ramtoola Z. (2000). Influence of particle size and dissolution condition on the degradation properties of polylactide-co-glycolide particles. Biomater 21:1659–68
   PubMed Web of Science ®Google Scholar
• Fazil M, Md S, Haque S, et al. (2012). Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci 47:6–15
   PubMed Web of Science ®Google Scholar
• Ge H, Hu Y, Jiang X, et al. (2002). Preparation, characterization, and drug release behaviors of drug nimodipine-loaded poly(e-caprolactone)–poly(ethylene oxide)–poly(e-caprolactone) amphiphilic triblock copolymer micelles. J Pharm Sci 91:1463–73
   PubMed Web of Science ®Google Scholar
• International Osteoporosis Foundation, http://www.iofbonehealth.org/osteoporosis-major-threat-women-and-their-future-independence-new-report-warns [last accessed 10 Oct, 2014]
   Google Scholar
• Govender T, Stolnik S, Garnett MC, Illum L, et al. (1999). PLGA nanoparticles prepared by nanoprecipitation drug loading and release studies of a water soluble drug. J Control Release 57:171–185
   PubMed Web of Science ®Google Scholar
• Hurson CJ, Butler JS, Keating DT, et al. (2007). Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis. BMC Musculoskelet Disord 8:1–12
   PubMed Web of Science ®Google Scholar
• Illum L. (2004). Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol 56:3–17
   PubMed Web of Science ®Google Scholar
• Joshi SA, Chavhan SS, Sawant KK, et al. (2010). Rivastigmine-loaded PLGA and PBCA NPs: preparation, optimization, characterization, in vitro and pharmacodynamic studies. Eur J Pharm Biopharm 76:189–99
   PubMed Web of Science ®Google Scholar
• Kyriakides D and Panderi I. (2007). Development and validation of a reversed-phase ion-pair high-performance liquid chromatographic method for the determination of risedronate in pharmaceutical preparations. Analytica Chimica Acta 584:153–9
   PubMed Web of Science ®Google Scholar
• Lanza F, Schwartz H, Sahba B, et al. (2000). An endoscopic comparison of the effects of alendronate and risedronate on upper gastrointestinal mucosae. Am J Gastroenterol 95:3112–17
   PubMed Web of Science ®Google Scholar
• Li WW, Kendler DL. (2004). Pharmaceutical care and community pharmacists understanding of bisphosphonate dosing information. J Clin Pharm Ther 2:531–36
   Web of Science ®Google Scholar
• Lin JH. (1996). Bisphosphonates: a review of their pharmacokinetic properties. Bone 18:75–85
   PubMed Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. (2011). Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymer 3:1377–97
   PubMed Web of Science ®Google Scholar
• McDonough AK, Curtis JR, Saag KG. (2008). The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol 2:131–7
   Google Scholar
• Mirza MA, Ahmad N, Agarwal SP, et al. (2011). Comparative evaluation of humic substances in oral drug delivery. Results in Pharm Sci 1:16–26
   PubMedGoogle Scholar
• Mitchell DY, Barr WH, Eusebio RA, et al. (2001). Risedronate pharmacokinetics and intra- and inter-subject variability upon single-dose intravenous and oral administration. Pharm Res 18:166–70
   PubMed Web of Science ®Google Scholar
• Mohanraj VJ, Chen Y. (2006). NPs – a review. Trop J Pharm Res 5:561–73
   Google Scholar
• Mori S, Sawai T, Teshima T, Kyogoku M. (1988). A new decalclfying technique for immunohistochemical studies of calcified tissue, especially applicable to cell surface marker demonstration. J Histochem Cytochem 36:111–14
   PubMed Web of Science ®Google Scholar
• Nam SH, Jeong JH, Che X, et al. (2012). Topically administered Risedronate shows powerful anti-osteoporosis effect in ovariectomized mouse model. Bone 50:149–55
   PubMed Web of Science ®Google Scholar
• Nasr M, Awad GAS, Mansour S, et al. (2011). Different modalities of NaCl osmogen in biodegradable microspheres for bone deposition of risedronate sodium by alveolar targeting. Eur J Pharm Biopharm 79:601–11
   PubMed Web of Science ®Google Scholar
• Regidor DL, Kovesdy CP, Mehrotra R, et al. (2008). Serum alkaline phosphatase predicts mortality among maintenance hemodialysis patients. J Am Soc Nephrol 19:2193–203
   PubMed Web of Science ®Google Scholar
• Richter T, Keipert S. (2004). In vitro permeation studies comparing bovine nasal mucosa, porcine cornea and artificial membrane: androstenedione in microemulsions and their components. Eur J Pharm Biopharm 58:137–43
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. (1987). A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release 5:37–42
   Google Scholar
• Seju U, Kumar A, Sawant KK. (2011). Development and evaluation of olanzapine-loaded PLGA nanoparticles for nose-to-brain delivery: in vitro and in vivo studies. Acta Biomater 7:4169–76
   PubMed Web of Science ®Google Scholar
• Shah N, Chaudhari K, Dantuluri P, et al. (2009). Paclitaxel-loaded PLGA nanoparticles surface modified with transferrin and Pluronic® P85, an in vitro cell line and in vivo biodistribution studies on rat model. J Drug Target 17:533–42
   PubMed Web of Science ®Google Scholar
• Silvermann SL, Maricic M. (2007). Recent developments in bisphosphonate therapy. Semin Arthritis Rheum 37:1–12
   PubMed Web of Science ®Google Scholar
• Song CX, Labhasetwar V, Murphy H, et al. (1997). Formulation and characterization of biodegradable nanoparticles for intravascular local drug delivery. J Control Release 43:197–212
   Web of Science ®Google Scholar
• Struijs A, Smals A, de Witte SA, et al. (2000). Acute effects of etidronate on glucocorticoid-induced bone degradation. Rheumatology 39:523–9
   PubMed Web of Science ®Google Scholar
• Vinogradov SV, Bronich TK, Kabanov AV. (2002). Nanosized cationic hydrogels for drug delivery: preparation, properties and interactions with cells. Adv Drug Deliv Rev 54:135–47
   PubMed Web of Science ®Google Scholar
• Yao W, Cheng Z, Pham A, et al. (2008). Glucocorticoid-induced bone loss in mice can be reversed by the actions of parathyroid hormone and risedronate on different pathways for bone formation and mineralization. Arthrit Rheumat 58:3485–97
   PubMed Web of Science ®Google Scholar